| Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons A Tottene, T Fellin, S Pagnutti, S Luvisetto, J Striessnig, C Fletcher, ... Proceedings of the National Academy of Sciences 99 (20), 13284-13289, 2002 | 337 | 2002 |
| Functional consequences of mutations in the human α1A calcium channel subunit linked to familial hemiplegic migraine M Hans, S Luvisetto, ME Williams, M Spagnolo, A Urrutia, A Tottene, ... Journal of Neuroscience 19 (5), 1610-1619, 1999 | 331 | 1999 |
| The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes S Marinelli, V Vacca, R Ricordy, C Uggenti, AM Tata, S Luvisetto, ... PLoS One 7 (10), e47977, 2012 | 156 | 2012 |
| Short-but not long-lasting treadmill running reduces allodynia and improves functional recovery after peripheral nerve injury S Cobianchi, S Marinelli, F Florenzano, F Pavone, S Luvisetto Neuroscience 168 (1), 273-287, 2010 | 131 | 2010 |
| Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain S Luvisetto, S Marinelli, S Cobianchi, F Pavone Neuroscience 145 (1), 1-4, 2007 | 124 | 2007 |
| Higher pain perception and lack of recovery from neuropathic pain in females: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice V Vacca, S Marinelli, L Pieroni, A Urbani, S Luvisetto, F Pavone PAIN® 155 (2), 388-402, 2014 | 123 | 2014 |
| Uncoupling of oxidative phosphorylation. 1. Protonophoric effects account only partially for uncoupling S Luvisetto, D Pietrobon, GF Azzone Biochemistry 26 (23), 7332-7338, 1987 | 109 | 1987 |
| Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice S Luvisetto, S Marinelli, F Lucchetti, F Marchi, S Cobianchi, O Rossetto, ... Brain research 1082 (1), 124-131, 2006 | 94 | 2006 |
| Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models S Marinelli, S Luvisetto, S Cobianchi, W Makuch, I Obara, E Mezzaroma, ... Neuroscience 171 (1), 316-328, 2010 | 89 | 2010 |
| Botulinum toxin type a as a therapeutic agent against headache and related disorders S Luvisetto, P Gazerani, C Cianchetti, F Pavone Toxins 7 (9), 3818-3844, 2015 | 88 | 2015 |
| The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord J Mika, E Rojewska, W Makuch, M Korostynski, S Luvisetto, S Marinelli, ... Neuroscience 175, 358-366, 2011 | 76 | 2011 |
| Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D S Luvisetto, E Basso, V Petronilli, P Bernardi, M Forte Neuroscience 155 (3), 585-596, 2008 | 76 | 2008 |
| Botulinum neurotoxin for pain management: insights from animal models F Pavone, S Luvisetto Toxins 2 (12), 2890-2913, 2010 | 75 | 2010 |
| Pain sensitivity in mice lacking the Cav2. 1α1 subunit of P/Q-type Ca2+ channels S Luvisetto, S Marinelli, MS Panasiti, FR D’amato, CF Fletcher, F Pavone, ... Neuroscience 142 (3), 823-832, 2006 | 72 | 2006 |
| 17beta-estradiol counteracts neuropathic pain: A behavioural, immunohistochemical and proteomic investigation on sex-related differences in mice V Vacca, S Marinelli, L Pieroni, A Urbani, S Luvisetto, F Pavone Scientific reports 6 (1), 18980, 2016 | 70 | 2016 |
| Participation of pro-and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain M Zychowska, E Rojewska, W Makuch, S Luvisetto, F Pavone, S Marinelli, ... European journal of pharmacology 791, 377-388, 2016 | 67 | 2016 |
| Uncoupling of oxidative phosphorylation. 2. Alternative mechanisms: intrinsic uncoupling or decoupling D Pietrobon, S Luvisetto, GF Azzone Biochemistry 26 (23), 7339-7347, 1987 | 63 | 1987 |
| Toxicity of botulinum neurotoxins in central nervous system of mice S Luvisetto, O Rossetto, C Montecucco, F Pavone Toxicon 41 (4), 475-481, 2003 | 55 | 2003 |
| Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and μ opioid receptor expression in … V Vacca, S Marinelli, S Luvisetto, F Pavone Brain, behavior, and immunity 32, 40-50, 2013 | 54 | 2013 |
| Modal Gating of Human CaV2.1 (P/Q-type) Calcium Channels: I. The Slow and the Fast Gating Modes and their Modulation by β Subunits S Luvisetto, T Fellin, M Spagnolo, B Hivert, PF Brust, MM Harpold, ... The Journal of general physiology 124 (5), 445-461, 2004 | 52 | 2004 |
